RBC Capital Maintains Outperform on Healthpeak Properties, Raises Price Target to $21

Benzinga Newsdesk www.benzinga.com Positive 89.6%

Neg 0% Neu 0% Pos 89.6%

RBC Capital analyst Michael Carroll maintains Healthpeak Properties (NYSE:DOC) with a Outperform and raises the price target from $20 to $21.